Indefinite Delivery Contract SPE2DR25D9760

The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities worldwide.

The IDC, which runs through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites. The original procurement was an unrestricted, fully competitive acquisition conducted by DLA Troop Support Medical Supply Chain to establish Pharmaceutical Prime Vendor Global Program Generation V contracts valued at an estimated $30.3 billion to support DoD, United States Coast Guard, and other government agency customers with worldwide pharmaceutical requirements.